TrialJournal of atherosclerosis and thrombosis2018

Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial.

Hidenori Arai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.